Resolve: p38α Inhibitor and PRMT1 Activator Combination to Restore Physiological TDP-43 Phosphorylation-Methylation Balance

Auto-generated challenge from hypothesis h-ccc05373 (score=0.848). Target: MAPK14/PRMT1. Question: Can targeting p38α Inhibitor and PRMT1 Activator Combination to Restore Physiological TDP-43 P lead to therapeutic benefit in neurodegeneration? Falsifiable prediction: TDP-43 phase separation normalization will restore RNA metabolism and reduce protein aggregates.

$250

OPEN

Confidence:

30%

Created: 2026-04-26

Linked Targets (2)

PRMT1 Protein arginine methyltransferase 1 PDB:1OR80.57

🧬 View 3D Structure — PDB 1OR8 click to expand

TARDBP TAR DNA-binding protein 43 PDB:2N3X0.51

🧬 View 3D Structure — PDB 2N3X click to expand

Landscape analysis not yet run for this challenge. Run the landscape analyzer to get competitive intelligence.

Linked Hypotheses (1)

p38α Inhibitor and PRMT1 Activator Combination to Restore Physiological TDP-43 P MAPK14/PRMT10.88